Cutar sankara ta coronavirus ta mamaye bil'adama tsawon shekaru uku ya zuwa yanzu.Tun daga Disamba 2022, an soke gwajin gwajin nucleic acid a wurare da yawa a cikin China, kuma ba za a sake duba takardar shaidar gwajin nucleic acid na COVID-19 ba.Kasar Sin ta shiga wani zamani na hadin gwiwa da annobar.Fuskantar yiwuwar kololuwar cututtuka, yadda ake inganta rigakafi da zama mutum na farko da ke da alhakin lafiyar ku ya zama batun da ya fi damun al'umma gaba ɗaya.

Kamar yadda fa'idar magungunan gargajiyar kasar Sin wajen yin rigakafi da shawo kan annobar ta kara yin fice,"Ganoderma lucidum“, wanda ke da tasirin haɓaka rigakafi da kiyaye daidaiton aikin gabaɗaya, ya yi fice sosai a cikin rigakafi da sarrafa cutar.

Don haka, yayiGanoderma lucidumShin kuna da wani tasiri mai hanawa akan novel coronavirus?Masu fama da COVID-19 na iya cin abinciGanoderma lucidumdon samun tasiri mai kyau a jiki?Sakamakon bincike da yawa na baya-bayan nan sun ba mu kyakkyawar shaida.

A cikin Afrilu 2020, mujallar ilimi ta duniyaKwayoyin halittaAn buga "Hanyoyin Bioactive na Halitta daga Fungi a matsayin Masu Neman Masu Taimako na Protease Inhibitors da Immunomodulators don Neman Coronaviruses".

Wannan takarda ta yi nazari kan ganowa da ci gaban bincike na mahaɗan gwangwani masu aiki na halitta don hana ƙwayoyin cuta na rigakafi na ɗan adam (HIV).Yana bada shawara cewa aiki mahadi na fungi, musammanGanoderma lucidum(triterpenoids, polysaccharides da ƙananan sunadaran kwayoyin halitta) suna taka muhimmiyar rawa wajen hana ƙwayoyin cuta na ƙwayoyin cuta (HIV).

Wannan binciken yana ba da ɗan takara mai yuwuwar magani don rigakafi da magani na coronaviruses, waɗanda za a iya amfani da su nan gaba don hanawa da kuma kula da coronaviruses, musamman don rigakafi da maganin cututtukan cututtukan ƙwayar cuta na coronavirus.

A cikin 2021, "Tsarin Cibiyar Nazarin Kimiyya ta Kasa (PNAS) 2021 Vol.118 No.5 ″ ya buga labarin "Gano masu hana cutar Coronavirus Novel Coronavirus daga Littattafan Magunguna da Magungunan Ganye".Binciken ya gano cewaGanoderma lucidumCire ruwa na iya hana kamuwa da cutar novel coronavirus (SARS-Cov-2) duka a cikin vivo da in vitro.

Cire ruwan maganin gargajiya na kasar Sin (1.0 g/20 ml, 5%) daGanoderma lucidumpolysaccharides RF3 (0.25 mg/ml, 0.025%).IC50 = rabin inhibitory (virus) kashi;CC50= Rabin kashi mai guba

Sakamakon ya tabbatar da hakaGanoderma lucidumpolysaccharide RF3 (2μg/ml) yana da babban tasirin antiviral akan SARS-Cov-2 al'adar in vitro, kuma har yanzu yana da ayyukan hanawa lokacin da aka diluted zuwa sau 1280.Amma ba shi da guba ga ƙwayoyin cutar Vero E6.

(A) Masu bincike sun lura da tasirin anti-sars-cov-2 na kwayoyi da tsantsa a cikin hamsters.A rana ta 0, hamsters sun kamu da cutar ta instillation na SARS-CoV-2.Bayan haka, an yi amfani da hamsters ta baki da miyagun ƙwayoyi (30mg/kg/d) da kuma maganin gargajiya na kasar Sin (200mg/kg/d), sau biyu / d, kuma an auna nauyin kwayar cutar a cikin huhu na hamsters bayan kwanaki 3. n = 5), * P <0.05;* * P <0.005 (B) Canjin nauyin jiki bayan jiyya na 3-d, N = 5 a cikin ƙungiyar gwaji, N = 6 a cikin ƙungiyar kulawa.Sakamakon ya tabbatar da cewa idan aka kwatanta da ƙungiyar kula da kamuwa da cuta, gudanar da baki naGanoderma lucidumpolysaccharide RF3 na iya rage girman nauyin hoto (abun ciki) a cikin huhu na hamsters da suka kamu da kwayar cutar SARS-Cov-2, kuma dabbobin ba su rasa nauyi ba yayin gwajin.In vivo da in vitro gwajin rigakafin cutar ya tabbatar da hakaGanoderma lucidumpolysaccharide RF3 ya hana SARS-Cov-2 kamuwa da cuta sosai.

A watan Fabrairun 2020, Farfesa Sun Guifan, mataimakin shugaban kwamitin kwararrun kwararrun masana abinci na kasar Sin na kungiyar abinci mai gina jiki da kiwon lafiya ta kasar Sin, da kuma Cibiyar Kula da Magunguna ta Jami'ar Kiwon Lafiya ta kasar Sin, sun fitar da labarin a bainar jama'a "Shahararriyar jerin labaran kimiyya ta biyu kan takamaiman taimako. a cikin rigakafi da kula da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan nau'i 12 da aka sanar ga jama'a.Ganoderma lucidum, maganin gargajiya na kasar Sin na ganye!

A cikin labarin, Farfesa Sun ya nuna hakan a filiGanoderma lucidumyana da tasiri na motsa jiki na rigakafi, wanda zai iya rinjayar ikonsa kai tsaye don yaƙar ƙwayoyin cuta da ƙwayoyin cuta.Laboratory cell nazarin ya nuna cewa Reishi tsantsa iya dakatar ko rage jinkirin ci gaban da mura cutar, HIV, hepatitis B da kuma da yawa wasu ƙwayoyin cuta, reversing shekaru da alaka rage a tsarin rigakafi aiki.

Farfesa Zhi-Bin Lin na Cibiyar Kiwon Lafiya ta Jami'ar Peking, wanda ya mayar da hankali kan binciken harhada magunguna naGanoderma lucidumfiye da shekaru 50, gabatar da antiviral sakamako da kuma inji naGanoderma luciduma cikin labarin "Antiviral Effect naGanoderma lucidum” da aka buga a ƙarshen 2020, yana nuna hakanGanoderma lucidum, musamman triterpenes dauke a cikiGanoderma lucidum, suna da tasirin hanawa akan ƙwayoyin cuta iri-iri.

Farfesa Zhi-Bin Lin tun da farko ya yi nazari kan tsarin tasirin rigakafin cutarGanoderma lucidum, wanda ya haɗa da hana adsorption ko shigar ƙwayoyin ƙwayoyin cuta zuwa ƙwayoyin cuta, hana cirewar ƙwayoyin cuta, hana ayyukan enzymes (kamar reverse transcriptase da protease) da ake buƙata don haɗin ƙwayoyin cuta a cikin sel, da hana kwayar cutar DNA ko RNA kwafi ammaGanoderma lucidumba shi da guba don karɓar sel kuma yana da tasirin haɗin gwiwa a hade tare da sanannun magungunan antiviral.

Labarin kuma ya nuna cewa tasirin asibiti naGanoderma lucidumakan cututtuka na hoto ko bidiyo mai zagaya yanar gizo da sauri na iya kasancewa da alaƙa da tasirin tsarin rigakafi naGanoderma lucidum, da anti-oxidation da free radical scavenging sakamako naGanoderma lucidum, da kuma tasirin kariya naGanoderma lucidumakan gabobi da kyallen takarda.

Binciken zamani ya nuna hakaGanoderma lucidumyana da wadata da yawa na sinadarai masu aiki, waɗanda sune “manzon” don haɓaka rigakafi.

Gabaɗaya magana, mafi girman abun ciki na sinadarai masu aiki, mafi kyawun tasirin haɓaka rigakafi.

Tun a farkon 2017, GanoHerb da Cibiyar Kula da Cututtuka ta lardin Fujian tare da haɗin gwiwa sun ƙaddamar da aikin bincike kan “TasirinGanoderma LucidumGranules akan Ayyukan rigakafi.An raba berayen zuwa rukuni biyar, kuma an ba su allurai daban-daban naGanoderma lucidumgranules (na GanoHerb Technology (Fujian) Corporation).

Ta hanyar kwatanta kowane nau'i na nau'in samfurin tare da ƙungiyar kulawa, an gano cewa: ①Kungiyoyin samfurori masu girma sun inganta haɓakar haɓakar ƙwayoyin lymphocytes na linzamin kwamfuta wanda aka haifar da ConA da kuma jinkirin jinkirin nau'in mice da DNFB ya haifar;②Kungiyoyi masu matsakaici da masu girma sun haɓaka ƙarfin haɓakar antibody, ƙungiyar masu girma da yawa sun haɓaka matakin hemolysin na jini a cikin mice;③Ƙungiyar samfurin ƙididdiga masu yawa sun inganta aikin ƙwayoyin NK a cikin mice.

Ƙarshen da aka zana daga gwajin shine cewa Ganoderma granules an tsara suGanoderma lucidumcire daGanoderma cutacirewa suna da aikin haɓaka rigakafi.A matsayinsa na babban kamfani mai mai da hankali kan masana'antar kiwon lafiya ta Ganoderma, tun bayan bullar annobar a shekarar 2020, GanoHerb ta ba da gudummawar tsabar kudi yuan miliyan 9.126 da kayayyakin da suka hada daGanoderma lucidumspore oil,Ganoderma lucidumspore foda daGanoderma lucidumcirewa don taimakawa ma'aikatan kiwon lafiya na gaba da sauran membobin ma'aikatan su inganta rigakafi da gina ingantaccen layin tsaro tare.Daidai saboda wannan nauyi da jajircewar da aka yi na yakar cutar a shekarar 2021, Kamfanin GanoHerb Technology (Fujian) Corporation., wani reshen GanoHerb Group, ya samu lambar yabo ta “Cibiyar Cigaban Kasuwancin Lardin Fujian a Yaki da Novel Coronary Pneumonia. Annoba".

Zaman gasa na rigakafi ya zo.Shin kun tanadi GanoHerb OrganicGanodermawanda ke ƙarfafa rigakafi kuma yana daidaita kuzari?